COVID-19 Advisory Board

Riscosity announces James Greene as CTO and Co-founder and welcomes Dr. Anand Singh as Chair of Riscosity's Advisory Council

Retrieved on: 
Wednesday, October 25, 2023

AUSTIN, Texas, Oct. 25, 2023 /PRNewswire-PRWeb/ -- Riscosity, a leading data security platform, today announced the appointment of James Greene as its new CTO and Co-founder and Dr. Anand Singh as a strategic advisor. Both have proven track records for driving growth, building strong teams, and accelerating development pipelines. James will oversee all aspects of Riscosity's Engineering organization, and Anand will lead the Data Security Advisory Council. He will chair Riscosity's advisory board and will work closely with Dr. Anirban Banerjee, Riscosity's CEO and Co-founder.

Key Points: 
  • Riscosity, a leading data security platform, today announced the appointment of James Greene as its new CTO and Co-founder and Dr. Anand Singh as a strategic advisor.
  • James will oversee all aspects of Riscosity's Engineering organization, and Anand will lead the Data Security Advisory Council.
  • AUSTIN, Texas, Oct. 25, 2023 /PRNewswire-PRWeb/ -- Riscosity, a leading data security platform, today announced the appointment of James Greene as its new CTO and Co-founder and Dr. Anand Singh as a strategic advisor.
  • James will oversee all aspects of Riscosity's Engineering organization, and Anand will lead the Data Security Advisory Council.

Two NYU Langone Health Faculty Elected to National Academy of Medicine

Retrieved on: 
Tuesday, October 24, 2023

NEW YORK, Oct. 24, 2023 /PRNewswire/ -- Céline R. Gounder, MD, ScM , and Robert Montgomery, MD, DPhil , two innovators at NYU Langone, have been elected to the National Academy of Medicine, one of the highest honors in their field.

Key Points: 
  • NEW YORK, Oct. 24, 2023 /PRNewswire/ -- Céline R. Gounder, MD, ScM , and Robert Montgomery, MD, DPhil , two innovators at NYU Langone, have been elected to the National Academy of Medicine, one of the highest honors in their field.
  • In a statement, the academy recognized her "for being one of the world's leading experts in communication about science, medicine, and public health.
  • Dr. Montgomery, is the H. Leon Pachter, MD, Professor of Surgery, chair of the Department of Surgery at NYU Grossman School of Medicine, and director of the NYU Langone Transplant Institute .
  • The academy addresses critical issues in health, science, medicine, and related policy and inspires positive actions across sectors.

Dr. Naval Parikh of South Florida Organizes Drive for Money and Supplies for Ukraine

Retrieved on: 
Wednesday, March 16, 2022

Naval Parikh of South Florida has organized a drive to collect money and supplies for Ukraine.

Key Points: 
  • Naval Parikh of South Florida has organized a drive to collect money and supplies for Ukraine.
  • Naval Parikh, a primary care physician, directed a drive to bring money and supplies to Ukraine that will help Ukrainians stay well-funded and well-supplied in their desperate fight for freedom.
  • Ukraine has a wealth of determination, but what it does not have is an inexhaustible amount of money and supplies.
  • Naval Parikh is more than a primary care doctor, he's a man of humanitarian ideals with a passion for helping people in need.

EIT Urban Mobility & Fira de Barcelona Launch Tomorrow.Mobility Advocating the Mobility of the Future

Retrieved on: 
Tuesday, November 16, 2021

Tomorrow.Mobility World Congress (TMWC) is a new global event, co-organised by Fira de Barcelona and EIT Urban Mobility, focused on promoting the design and adoption of new sustainable urban mobility models.

Key Points: 
  • Tomorrow.Mobility World Congress (TMWC) is a new global event, co-organised by Fira de Barcelona and EIT Urban Mobility, focused on promoting the design and adoption of new sustainable urban mobility models.
  • View the full release here: https://www.businesswire.com/news/home/20211116005046/en/
    Tomorrow.Mobility World Congress: The ultimate global event on sustainable and intelligent urban mobility (Graphic: EIT Urban Mobility)
    EIT Urban Mobility is the largest European initiative for the transformation of urban mobility, created by the European Institute of Innovation and Technology (EIT), a body of the European Union.
  • Dr. Maria Tsavachidis, CEO of EIT Urban Mobility & President of the Advisory Board of TMWC stated that our collaboration with Fira de Barcelona will help expand the network of innovation for urban mobility in Europe and beyond.
  • As the leading European innovation community for urban mobility, EIT Urban Mobility works to avoid fragmentation by facilitating collaboration between cities, industry, academia, research and innovation to solve the most pressing mobility challenges of cities.

Noblis Appoints Dr. Luciana Borio to Board of Trustees

Retrieved on: 
Monday, October 25, 2021

RESTON, Va., Oct. 25, 2021 /PRNewswire/ -- Noblis , a leading provider of science, technology and strategy services to the federal government, today announced that it has appointed medical and public health leader, Luciana Borio, M.D., to its Board of Trustees.

Key Points: 
  • RESTON, Va., Oct. 25, 2021 /PRNewswire/ -- Noblis , a leading provider of science, technology and strategy services to the federal government, today announced that it has appointed medical and public health leader, Luciana Borio, M.D., to its Board of Trustees.
  • "As a recognized specialist in biodefense, emerging infectious diseases, medical product development and complex public health emergencies, Dr. Borio shares Noblis' mission to enrich lives and protect our nation," said Michael Chertoff, chairman, Noblis Board of Trustees .
  • "I'm delighted to join Noblis' Board of Trustees," said Dr. Borio.
  • Noblis is a dynamic science, technology and strategy organization dedicated to creating forward-thinking technical and advisory solutions in the public interest.

Immunome Reports Second Quarter 2021 Financial Results

Retrieved on: 
Thursday, August 19, 2021

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update.

Key Points: 
  • Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update.
  • We believe we are well-positioned for an IND filing for this program in the third quarter, said Purnanand Sarma, Ph.D., President and CEO of Immunome.
  • In July 2021, Immunome announced that its three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against the SARS-CoV-2 Delta variant in pre-clinical pseudovirus testing.
  • In April 2021, Immunome announced that it had appointed Corleen Roche as its Chief Financial Officer.

Ariadne Labs and Genomes2People Launch New Precision Population Health Initiative

Retrieved on: 
Tuesday, March 23, 2021

BOSTON, March 23, 2021 /PRNewswire/ --Ariadne Labs today announced the launch of the Precision Population Health initiative.

Key Points: 
  • BOSTON, March 23, 2021 /PRNewswire/ --Ariadne Labs today announced the launch of the Precision Population Health initiative.
  • Ariadne Labs has been exploring the role of precision medicine in primary health care since 2018 as part of the organization's Spark Grant innovation incubation pipeline .
  • "If precision medicine is to be fully integrated into population health and the day-to-day practice of medicine at scale, significant health system innovations will be required," said Atul Gawande, MD, MPH, Founder and Chair of Ariadne Labs.
  • "We are excited to be collaborating on this important Precision Population Health initiative.

Infectious disease expert, Dr. Michael T. Osterholm briefs Collective[i] Forecast community on COVID-19: "We're at the most dangerous moment in public health history since 1918."

Retrieved on: 
Tuesday, November 24, 2020

In this virtual briefing for Collective[i] clients and community members, Dr. Osterholm discussed the evolving reality of the COVID-19 pandemic, and what to expect as we enter 2021.

Key Points: 
  • In this virtual briefing for Collective[i] clients and community members, Dr. Osterholm discussed the evolving reality of the COVID-19 pandemic, and what to expect as we enter 2021.
  • Dr. Osterholm advised against traveling for Thanksgiving as well as large holiday gatherings.
  • Though many are experiencing what he refers to as "pandemic fatigue," Dr. Osterholm warned that "we're at the most dangerous moment in public health history since 1918."
  • Collective[i]'s application and network augment traditional CRM with AI, surfacing every advantage a modern sales organization needs to win.